BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 17954156)

  • 1. The influence of HLA mismatches and immunosuppression on kidney graft survival: an analysis of more than 1300 patients.
    Martins L; Fonseca I; Sousa S; Matos C; Santos J; Dias L; Henriques AC; Sarmento AM; Cabrita A
    Transplant Proc; 2007 Oct; 39(8):2489-93. PubMed ID: 17954156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of immunosuppressive regimens on graft survival and secondary outcomes after kidney transplantation.
    Opelz G; Döhler B;
    Transplantation; 2009 Mar; 87(6):795-802. PubMed ID: 19300179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA mismatches remain risk factors for acute kidney allograft rejection in patients receiving quadruple immunosuppression with anti-interleukin-2 receptor antibodies.
    Wissing KM; Fomegné G; Broeders N; Ghisdal L; Hoang AD; Mikhalski D; Donckier V; Vereerstraeten P; Abramowicz D
    Transplantation; 2008 Feb; 85(3):411-6. PubMed ID: 18322434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-center analysis of 468 first cadaveric kidney allografts with a uniform ATG-CsA sequential therapy.
    Giral M; Taddei C; Nguyen JM; Dantal J; Hourmant M; Cantarovich D; Blancho G; Ancelet D; Soulillou JP
    Clin Transpl; 1996; ():257-64. PubMed ID: 9286575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and socioeconomic benefits of serological HLA-DR matching for renal transplantation over three eras of immunosuppression regimens at a single unit.
    Taylor CJ; Welsh KI; Gray CM; Bunce M; Bayne AM; Sutton PM; Gray DW; Ting A; Morris PJ
    Clin Transpl; 1993; ():233-41. PubMed ID: 7918156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppression modifications and graft outcome in patients with chronic allograft nephropathy.
    El-Agroudy AE; El-Dahshan K; Mahmoud K; Ismail AM; El-Baz M; Shokeir AA; Ghoneim MA
    Exp Clin Transplant; 2008 Sep; 6(3):203-10. PubMed ID: 18954298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acute rejection in cadaveric renal transplantation under cyclosporine based therapy. Analysis of the risk factors and its influence on chronic dysfunction].
    Mota A
    Acta Med Port; 2004; 17(1):8-14. PubMed ID: 15636737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicenter analysis of the significance of HLA matching on outcomes after kidney-pancreas transplantation.
    Lo A; Stratta RJ; Alloway RR; Hodge EE;
    Transplant Proc; 2005 Mar; 37(2):1289-90. PubMed ID: 15848699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human leukocyte antigen mismatches associated with increased risk of rejection, graft failure, and death independent of initial immunosuppression in renal transplant recipients.
    Lim WH; Chadban SJ; Clayton P; Budgeon CA; Murray K; Campbell SB; Cohney S; Russ GR; McDonald SP
    Clin Transplant; 2012; 26(4):E428-37. PubMed ID: 22672477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organ sharing for good HLA-A,B, and DR matching improves cadaver renal graft survival in SEOPF: retrospective and prospective studies considering delayed graft function, race, center effects, cyclosporine, and other factors.
    Sanfilippo F; Vaughn WK; Alexander JW; LeFor WM; Lucas BA; Pfaff WW
    Clin Transpl; 1988; ():211-23. PubMed ID: 3154474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
    Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of initial immunosuppression on long-term kidney transplant outcome in immunological low-risk patients.
    Michielsen LA; van Zuilen AD; Verhaar MC; Wisse BW; Kamburova EG; Joosten I; Allebes WA; van der Meer A; Baas MC; Spierings E; Hack CE; van Reekum FE; Bots ML; Drop ACAD; Plaisier L; Seelen MAJ; Sanders JF; Hepkema BG; Lambeck AJ; Bungener LB; Roozendaal C; Tilanus MGJ; Voorter CE; Wieten L; van Duijnhoven EM; Gelens MACJ; Christiaans MHL; van Ittersum FJ; Nurmohamed SA; Lardy NM; Swelsen W; van der Pant KA; van der Weerd NC; Ten Berge IJM; Bemelman FJ; Hoitsma A; van der Boog PJM; de Fijter JW; Betjes MGH; Heidt S; Roelen DL; Claas FH; Otten HG; Hilbrands LB
    Nephrol Dial Transplant; 2019 Aug; 34(8):1417-1422. PubMed ID: 30561730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of donor/recipient HLA-matching on outcome and recurrence of hepatitis C after liver transplantation.
    Langrehr JM; Puhl G; Bahra M; Schmeding M; Spinelli A; Berg T; Schönemann C; Krenn V; Neuhaus P; Neumann UP
    Liver Transpl; 2006 Apr; 12(4):644-51. PubMed ID: 16555324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spanish experience with cyclosporine.
    Pascual J; Marcén R; Burgos FJ; Villafruela JJ; Teruel JL; Mampaso F; Quereda C; Ortuño J
    Transplant Proc; 2004 Mar; 36(2 Suppl):117S-119S. PubMed ID: 15041319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cold ischemia is a major determinant of acute rejection and renal graft survival in the modern era of immunosuppression.
    Mikhalski D; Wissing KM; Ghisdal L; Broeders N; Touly M; Hoang AD; Loi P; Mboti F; Donckier V; Vereerstraeten P; Abramowicz D
    Transplantation; 2008 Apr; 85(7 Suppl):S3-9. PubMed ID: 18401260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance immunosuppression.
    Takemoto SK
    Clin Transpl; 2000; ():481-95. PubMed ID: 11512360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of mismatching and sharing of HLA-A, -B, and -DR antigens on kidney graft survival in Eurotransplant 1982 to 1988.
    Persijn GG; D'Amaro J; De Lange P; Schreuder GM; Thorogood J; Zantvoort F; Van Rood JJ
    Clin Transpl; 1988; ():237-48. PubMed ID: 3154476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of graft nephrectomy in pre-cyclosporine and cyclosporine era.
    Adhikary SD; Viswaroop SB; Kekre NS; Gopalakrishnan G
    Urol Int; 2008; 80(1):80-3. PubMed ID: 18204239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of mycophenolate mofetil and HLA matching on renal allograft survival.
    Meier-Kriesche HU; Ojo AO; Leichtman AB; Magee JC; Rudich SM; Hanson JA; Cibrik DM; Kaplan B
    Transplantation; 2001 Feb; 71(3):398-401. PubMed ID: 11233900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of HLA matching on survival in heart transplantation.
    Almenar L; Maeso ML; Martínez-Dolz L; Rueda J; Palomar CG; Sáez AO; Vives MA; Tort MD; Pérez MP
    Transplant Proc; 2005 Nov; 37(9):4001-5. PubMed ID: 16386610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.